These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19353475)

  • 21. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.
    Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH
    Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine-preventable diseases in health care.
    Kessler ER
    Occup Med; 1997; 12(4):731-9. PubMed ID: 9353820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Whether chicken pox or polio, mumps, measles or rubella. Patience and persistence are needed if vaccination programs are to succeed].
    Liese J
    MMW Fortschr Med; 2005 Feb; 147(8):30. PubMed ID: 18441562
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of measles vaccines in Japan.
    Ueda S
    Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic actions of the risks and adverse events associated with vaccine administration.
    Moylett EH; Hanson IC
    J Allergy Clin Immunol; 2004 Nov; 114(5):1010-20; quiz 1021. PubMed ID: 15536401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles, mumps and rubella--safety of the combined vaccine.
    Bedford H
    Nurs Times; 2004 Mar 2-8; 100(9):74-5. PubMed ID: 15038137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inoculation rates of children starting school in Bavaria].
    Morlock G; Arenz S; Wildner M
    MMW Fortschr Med; 2005 Feb; 147(8):41, 43-4. PubMed ID: 18441564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles and rubella immunisation campaign. Safety untested.
    Stephenson R
    BMJ; 1994 Oct; 309(6962):1162. PubMed ID: 7987136
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.
    Tillieux SL; Halsey WS; Sathe GM; Vassilev V
    Vaccine; 2009 Apr; 27(16):2265-73. PubMed ID: 19428841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits, risks and costs of viral vaccines.
    Koplan JP; Axnick NW
    Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mumps resurgence in the United States.
    Kancherla VS; Hanson IC
    J Allergy Clin Immunol; 2006 Oct; 118(4):938-41. PubMed ID: 17030249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of the rubella vaccine and vaccination strategy in Japan.
    Ueda K
    Vaccine; 2009 May; 27(24):3232-3. PubMed ID: 19366581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines: the wave of the future.
    Brennan B
    Perspect Health; 1998; 3(2):17-21. PubMed ID: 12322198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naive and memory CD4+ T-cells in the cerebrospinal fluid of children with aseptic meningitis following measles-mumps-rubella vaccination and enteroviral meningitis.
    Lepej SZ; Tesovic G; Sternak SL; Jeren T
    Immunol Invest; 2007; 36(3):321-35. PubMed ID: 17558714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children's health and the social theory of risk: insights from the British measles, mumps and rubella (MMR) controversy.
    Casiday RE
    Soc Sci Med; 2007 Sep; 65(5):1059-70. PubMed ID: 17540488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.